Court in Regenerative Sciences Case: Propagated Stem Cells Are Drugs
A long-standing debate in the commercial stem cell arena has focused on whether stem cells grown in a lab prior to clinical use as a transplantation product are biological drugs subject to full FDA vetting. The alternative view has been that such stem cell products are not drugs, but rather are simple human cellular and […]
Court in Regenerative Sciences Case: Propagated Stem Cells Are Drugs Read More »